PA8549801A1 - Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales - Google Patents
Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animalesInfo
- Publication number
- PA8549801A1 PA8549801A1 PA20028549801A PA8549801A PA8549801A1 PA 8549801 A1 PA8549801 A1 PA 8549801A1 PA 20028549801 A PA20028549801 A PA 20028549801A PA 8549801 A PA8549801 A PA 8549801A PA 8549801 A1 PA8549801 A1 PA 8549801A1
- Authority
- PA
- Panama
- Prior art keywords
- mycoplasma bovis
- vaccine
- animals
- methods
- vaccines
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 8
- 241001138504 Mycoplasma bovis Species 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 241001465754 Metazoa Species 0.000 title abstract 2
- 206010035664 Pneumonia Diseases 0.000 title 1
- 241000204003 Mycoplasmatales Species 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940023146 nucleic acid vaccine Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30263801P | 2001-07-02 | 2001-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8549801A1 true PA8549801A1 (es) | 2003-09-17 |
Family
ID=23168600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20028549801A PA8549801A1 (es) | 2001-07-02 | 2002-07-02 | Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20030147914A1 (enExample) |
| EP (1) | EP1401488A1 (enExample) |
| JP (1) | JP2004536106A (enExample) |
| KR (1) | KR20040030783A (enExample) |
| CN (1) | CN1522152A (enExample) |
| AP (1) | AP2002002568A0 (enExample) |
| AR (1) | AR036125A1 (enExample) |
| BG (1) | BG108496A (enExample) |
| BR (1) | BR0210798A (enExample) |
| CA (1) | CA2452580A1 (enExample) |
| CZ (1) | CZ20033465A3 (enExample) |
| EA (1) | EA200301324A1 (enExample) |
| GT (1) | GT200200139A (enExample) |
| HN (1) | HN2002000162A (enExample) |
| HR (1) | HRP20031078A2 (enExample) |
| HU (1) | HUP0501188A2 (enExample) |
| IL (1) | IL159516A0 (enExample) |
| IS (1) | IS7078A (enExample) |
| MA (1) | MA27048A1 (enExample) |
| MX (1) | MXPA03011815A (enExample) |
| NO (1) | NO20035767L (enExample) |
| OA (1) | OA12640A (enExample) |
| PA (1) | PA8549801A1 (enExample) |
| PE (1) | PE20030239A1 (enExample) |
| PL (1) | PL373891A1 (enExample) |
| SK (1) | SK15802003A3 (enExample) |
| TN (1) | TNSN03154A1 (enExample) |
| UY (1) | UY27365A1 (enExample) |
| WO (1) | WO2003004052A1 (enExample) |
| YU (1) | YU102103A (enExample) |
| ZA (1) | ZA200309747B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| SE0301436D0 (sv) * | 2003-05-16 | 2003-05-16 | Joakim Westberg | New proteins |
| US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| US20090068223A1 (en) * | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| WO2008030619A2 (en) * | 2006-09-07 | 2008-03-13 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| MX2009001849A (es) | 2006-09-11 | 2009-03-02 | Pfizer Prod Inc | Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor. |
| CL2008003202A1 (es) * | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| NZ589981A (en) * | 2008-07-03 | 2012-11-30 | Univ Iowa State Res Found Inc | Cattle vaccines comprising a disrupted M. bovis bacterium |
| AU2009309041B2 (en) * | 2008-10-31 | 2016-02-04 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| KR20170077255A (ko) | 2009-06-04 | 2017-07-05 | 고쿠리츠칸센쇼켄쿠죠 | 마이코플라즈마 감염증용 백신 |
| CN102220263B (zh) * | 2011-05-06 | 2012-10-03 | 华中农业大学 | 一种牛支原体致弱菌株及其应用 |
| UA121193C2 (uk) | 2012-12-28 | 2020-04-27 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Спосіб одержання імуногенної композиції проти мікоплазми |
| CN104857509A (zh) * | 2015-06-02 | 2015-08-26 | 福清市默克兽医院 | 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法 |
| CN108135989B (zh) | 2015-08-14 | 2022-08-09 | 硕腾服务有限责任公司 | 牛支原体组合物 |
| CN105441368B (zh) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | 一株牛支原体及其应用 |
| CN106929452B (zh) * | 2017-04-11 | 2020-06-12 | 河南省农业科学院畜牧兽医研究所 | 一株牛支原体及其应用 |
| CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
| CN110338138B (zh) * | 2019-06-19 | 2021-04-06 | 山东省农业科学院奶牛研究中心 | 一种牛支原体感染豚鼠的动物模型构建方法及其应用 |
| CN112301041B (zh) * | 2020-10-09 | 2022-05-24 | 华中农业大学 | 牛支原体p21蛋白及其应用 |
| CN113546162B (zh) * | 2021-05-31 | 2023-07-18 | 江苏省农业科学院 | 一种支原体疫苗及其制备方法 |
| CN113604492B (zh) * | 2021-09-10 | 2023-07-07 | 苏州世诺生物技术有限公司 | 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| CA2390613A1 (en) * | 1999-11-08 | 2001-05-17 | Biomune | Vaccines for mycoplasma bovis and methods of use |
| DE29921392U1 (de) * | 1999-12-06 | 2000-03-16 | Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben | Mykoplasma-bovis-Kombinations-Vakzine für Rinder |
| US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
-
2002
- 2002-06-20 US US10/177,857 patent/US20030147914A1/en not_active Abandoned
- 2002-06-27 JP JP2003510062A patent/JP2004536106A/ja active Pending
- 2002-06-27 EA EA200301324A patent/EA200301324A1/ru unknown
- 2002-06-27 WO PCT/IB2002/002514 patent/WO2003004052A1/en not_active Ceased
- 2002-06-27 HU HU0501188A patent/HUP0501188A2/hu unknown
- 2002-06-27 HR HR20031078A patent/HRP20031078A2/hr not_active Application Discontinuation
- 2002-06-27 AP APAP/P/2002/002568A patent/AP2002002568A0/en unknown
- 2002-06-27 SK SK1580-2003A patent/SK15802003A3/sk not_active Application Discontinuation
- 2002-06-27 CZ CZ20033465A patent/CZ20033465A3/cs unknown
- 2002-06-27 TN TNPCT/IB2002/002514A patent/TNSN03154A1/fr unknown
- 2002-06-27 OA OA1200300346A patent/OA12640A/en unknown
- 2002-06-27 IL IL15951602A patent/IL159516A0/xx unknown
- 2002-06-27 PL PL02373891A patent/PL373891A1/xx unknown
- 2002-06-27 EP EP02738544A patent/EP1401488A1/en not_active Withdrawn
- 2002-06-27 CN CNA028132882A patent/CN1522152A/zh active Pending
- 2002-06-27 BR BRPI0210798-8A patent/BR0210798A/pt not_active IP Right Cessation
- 2002-06-27 KR KR10-2004-7000003A patent/KR20040030783A/ko not_active Ceased
- 2002-06-27 MX MXPA03011815A patent/MXPA03011815A/es unknown
- 2002-06-27 CA CA002452580A patent/CA2452580A1/en not_active Abandoned
- 2002-06-27 YU YU102103A patent/YU102103A/sh unknown
- 2002-06-28 HN HN2002000162A patent/HN2002000162A/es unknown
- 2002-07-01 AR ARP020102480A patent/AR036125A1/es unknown
- 2002-07-01 UY UY27365A patent/UY27365A1/es not_active Application Discontinuation
- 2002-07-01 PE PE2002000592A patent/PE20030239A1/es not_active Application Discontinuation
- 2002-07-02 PA PA20028549801A patent/PA8549801A1/es unknown
- 2002-07-02 GT GT200200139A patent/GT200200139A/es unknown
-
2003
- 2003-12-15 IS IS7078A patent/IS7078A/is unknown
- 2003-12-17 ZA ZA200309747A patent/ZA200309747B/xx unknown
- 2003-12-22 NO NO20035767A patent/NO20035767L/no not_active Application Discontinuation
- 2003-12-22 BG BG108496A patent/BG108496A/xx unknown
- 2003-12-31 MA MA27469A patent/MA27048A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN03154A1 (fr) | 2005-12-23 |
| HN2002000162A (es) | 2002-09-17 |
| HRP20031078A2 (en) | 2005-08-31 |
| MXPA03011815A (es) | 2004-04-02 |
| SK15802003A3 (sk) | 2005-01-03 |
| PE20030239A1 (es) | 2003-03-21 |
| KR20040030783A (ko) | 2004-04-09 |
| WO2003004052A1 (en) | 2003-01-16 |
| BG108496A (en) | 2005-02-28 |
| IL159516A0 (en) | 2004-06-01 |
| JP2004536106A (ja) | 2004-12-02 |
| AR036125A1 (es) | 2004-08-11 |
| EA200301324A1 (ru) | 2004-12-30 |
| EP1401488A1 (en) | 2004-03-31 |
| HUP0501188A2 (en) | 2006-05-29 |
| NO20035767L (no) | 2004-01-30 |
| IS7078A (is) | 2003-12-15 |
| CA2452580A1 (en) | 2003-01-16 |
| BR0210798A (pt) | 2006-05-23 |
| US20030147914A1 (en) | 2003-08-07 |
| MA27048A1 (fr) | 2004-12-20 |
| UY27365A1 (es) | 2003-04-30 |
| GT200200139A (es) | 2003-02-13 |
| PL373891A1 (en) | 2005-09-19 |
| ZA200309747B (en) | 2005-05-27 |
| CN1522152A (zh) | 2004-08-18 |
| YU102103A (sh) | 2006-05-25 |
| OA12640A (en) | 2006-06-15 |
| CZ20033465A3 (cs) | 2004-12-15 |
| AP2002002568A0 (en) | 2002-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8549801A1 (es) | Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales | |
| PA8549701A1 (es) | Vacunacion en dosis unica con mycoplasma hyopneumoniae | |
| AR034677A1 (es) | Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado | |
| MX2020010941A (es) | Moleculas y composiciones novedosas de arn de vsr para vacunacion. | |
| WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
| BR112022016507A2 (pt) | Vacinas contra o coronavírus e métodos de uso | |
| NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
| Cooke et al. | Cellular adhesive phenomena in apicomplexan parasites of red blood cells | |
| AR036355A1 (es) | Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas | |
| BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
| UY26763A1 (es) | Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo. | |
| ATE442857T1 (de) | Vakzine zusammensetzung zur impfung von hunden gegen infektiöse atemwegserkrankung bei hunden (cird) | |
| JP5865839B2 (ja) | 粘膜アジュバント組成物 | |
| MX2023005154A (es) | Nanopartículas codificadas de adn y método de uso de las mismas como una vacuna contra la enfermedad corona virus (covid-19). | |
| AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv | |
| DE602005011041D1 (de) | Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort | |
| Barnard | BRD in dairy calves: Peace of mind through vaccination | |
| BR0110791A (pt) | Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo | |
| RU2539105C1 (ru) | Препарат для лечения некробактериоза крупного рогатого скота | |
| MX2023000097A (es) | Adyuvantes de vacunas y metodos de sintetizacion y uso de estos. | |
| RU2213573C2 (ru) | Способ профилактики паратифа телят | |
| El-Bagoury et al. | Comparative evaluation of different inactivated Rift valley fever virus vaccine adjuvanted with montanide oil ISA 61 VG, montanide oil ISA 201 VG, and aluminum hydroxide gel | |
| CY1116862T1 (el) | Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae | |
| El-Bagoury et al. | Evaluation of inactivated Rift valley fever virus vaccine adjuvanted with montanide oil ISA 201 VG | |
| Hussey et al. | Duration of immunity to equine influenza virus resulting from canarypox-vectored vaccination. |